Search PubMed⌕ Search

PubMed · 15358711

European framework to decrease the burden of TB/HIV.

Abstract

Tuberculosis (TB) in Europe is declining in countries in western and central Europe, but the burden is still high and increasing in eastern Europe. HIV/AIDS is increasing dramatically in eastern Europe. HIV-related tuberculosis (TB/HIV) morbidity and mortality are expected to accelerate significantly in the future. This framework aims to guide European countries in developing their national plan for reducing TB/HIV morbidity and mortality. It results from an extensive consultation process undertaken by the World Health Organization Regional Office for Europe and by those responsible for HIV/AIDS and TB programmes and their partners. It builds on strategies developed globally and in Europe for TB control and for HIV/AIDS prevention and care. This framework sets out the rationale for effective collaboration between HIV/AIDS and tuberculosis national programmes. It identifies five strategic components (political commitment, collaborative prevention, intensified case-finding, coordinated treatment and strengthened surveillance) and eight key operations (central coordination, policy development, surveillance, training, supply management, service delivery, health promotion and research).

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

P de Colombani, N Banatvala, R Zaleskis, D Maher, WHO regional office for Europe. 2004. European framework to decrease the burden of TB/HIV.. https://doi.org/10.1183/09031936.04.00064504

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Progress toward elimination of measles and prevention of congenital rubella infection--European region, 1990-2004.

The European Region (EUR) of the World Health Organization (WHO) comprises 52 member countries, with an estimated population of 876 million. In 1998, the Regional Committee for EUR resolved to interrupt indigenous measles transmission by 2007 and reduce the incidence of congenital rubella syndrome (CRS) in all countries to <1 per 100,000 live births by 2010. In 2002, progress toward these measles and rubella targets was further encouraged with development of the Strategic Plan for Measles and Congenital Rubella Infection in the WHO European Region, which outlines an integrated approach to achieving both disease targets by 2010 by implementing six key strategies. This report presents data on measles, rubella, and CRS control in EUR during 1990-2004 and summarizes progress halfway through the implementation of the strategic plan.

Europe↗